Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
| dc.creator | Jin, Zhenming | |
| dc.creator | Zhao, Yao | |
| dc.creator | Sun, Yuan | |
| dc.creator | Zhang, Bing | |
| dc.creator | Wang, Haofeng | |
| dc.creator | Wu, Yan | |
| dc.creator | Zhu, Yan | |
| dc.creator | Zhu, Chen | |
| dc.creator | Hu, Tianyu | |
| dc.creator | Du, Xiaoyu | |
| dc.creator | Duan, Yinkai | |
| dc.creator | Yu, Jing | |
| dc.creator | Yang, Xiaobao | |
| dc.creator | Yang, Xiuna | |
| dc.creator | Yang, Kailin | |
| dc.creator | Liu, Xiang | |
| dc.creator | Guddat, Luke W. | |
| dc.creator | Xiao, Gengfu | |
| dc.creator | Zhang, Leike | |
| dc.creator | Yang, Haitao | |
| dc.creator | Rao, Zihe | |
| dc.date.accessioned | 2020-07-17T14:21:46Z | |
| dc.date.available | 2020-07-17T14:21:46Z | |
| dc.date.created | 2020-05-07 | |
| dc.description.abstractenglish | The antineoplastic drug carmofur is shown to inhibit the SARS-CoV-2 main protease (Mpro). Here, the X-ray crystal structure of Mpro in complex with carmofur reveals that the carbonyl reactive group of carmofur is covalently bound to catalytic Cys145, whereas its fatty acid tail occupies the hydrophobic S2 subsite. Carmofur inhibits viral replication in cells (EC50 = 24.30 μM) and is a promising lead compound to develop new antiviral treatment for COVID-19. | spa |
| dc.format.extent | 10 páginas | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.doi | https://doi.org/10.1038/s41594-020-0440-6 | spa |
| dc.identifier.issn | 1545-9985 | spa |
| dc.identifier.other | https://www.nature.com/articles/s41594-020-0440-6 | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12010/10718 | |
| dc.publisher | Science Direct | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.source | reponame:Expeditio Repositorio Institucional UJTL | spa |
| dc.source | instname:Universidad de Bogotá Jorge Tadeo Lozano | spa |
| dc.subject | Carmofur | spa |
| dc.subject.keyword | Carmofur | spa |
| dc.subject.lemb | Síndrome respiratorio agudo grave | spa |
| dc.subject.lemb | COVID-19 | spa |
| dc.subject.lemb | SARS-CoV-2 | spa |
| dc.subject.lemb | Coronavirus | spa |
| dc.title | Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur | spa |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
| dc.type.local | Artículo | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- s41594-020-0440-6.pdf
- Tamaño:
- 4.18 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Documento reservado
Bloque de licencias
1 - 1 de 1
Cargando...
- Nombre:
- license.txt
- Tamaño:
- 2.87 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción:
